Literature DB >> 263324

Heterogeneous human prolactin from a giant pituitary tumor in a patient with panhypopituitarism.

V S Fang, S Refetoff.   

Abstract

A patient with hypopituitarism and an unusually large chromophobe adenoma which secreted an enormous amount of human PRL (hPRL) provided us with a unique opportunity to study the heterogeneity of hPRL. Serum samples obtained before and after surgery as well as pituitary extract were studied. Each sample contained three distinct hPRL peaks on gel filtration designated as big medium, and small. The hPRL moiety of each peak fraction was stable in size, immunoreactivity, and bioreactivity, indicating that the polymorphic hPRL components, once formed, were not interconvertible. As the relative proportion of medium and small hPRL components in all blood samples obtained before surgery and in the pituitary tumor extracts were similar, it seems that these two forms of hPRL originate from the tumor. However, there was a lack of correlation between big, medium, and small hPRL in samples obtained before and 1 yr after surgery. Also, increasing amounts of radioactive substance similar to increasing amounts of radioactive substance similar to big PRL were formed by exposure of 125I-labeled small PRL to progressively larger concentrations of serum. Thus, only small and possibly medium PRL are secretory products.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263324     DOI: 10.1210/jcem-47-4-780

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia.

Authors:  H Tamai; O Mizuno; A Takaki; K Kiyohara; G Komaki; S Matsubayashi; K Kuma; L F Kumagai; S Nagataki
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

2.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

3.  Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.

Authors:  B Cavaco; S Prazeres; M A Santos; L G Sobrinho; V Leite
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.

Authors:  M Guitelman; M E Colombani-Vidal; C C Zylbersztein; L Fiszlejder; M Zeller; O Levalle; H E Scaglia
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

6.  Unusual heterogeneity of circulating prolactin in an acromegalic.

Authors:  A D Rogol; R C Eastman; T Manolio; S W Rosen
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.